Advertisement

Topics

Plaque Psoriasis Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

11:14 EDT 3 Sep 2017 | BioPortfolio Reports

DelveInsight's Plaque Psoriasis Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Plaque Psoriasis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Plaque Psoriasis. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Plaque Psoriasis. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

The Report includes the prevalent population and how will it change over the next eight years.
Coverage of key Plaque Psoriasis subpopulations and its prevalent or incident cases
Prevalent or incident cases segmented by age and sex.
The key differences in epidemiology patterns across the seven market segments.

Reasons to buy
Developing business strategies by understanding the trends shaping and driving the global Plaque Psoriasis market.
Identifying prevalent patient populations as well as risk factors in the global Plaque Psoriasis market will help to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Plaque Psoriasis therapeutics in each of the markets covered.

Original Article: Plaque Psoriasis Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

NEXT ARTICLE

More From BioPortfolio on "Plaque Psoriasis Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950"

Quick Search
Advertisement
 

Relevant Topics

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...